Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,272 total articles

Nocera Highlights CampaignPulse.ai Platform Capabilities and Expanding AI Intelligence Opportunity Following Strategic Investment

Nocera Highlights CampaignPulse.ai Platform Capabilities and Expanding AI Intelligence Opportunity Following Strategic Investment

Nocera, Inc. announces a minority equity investment in CampaignPulse.ai, an AI-powered campaign intelligence platform designed to simulate and analyze audience reactions for optimizing messaging and strategies. The company also advances a partnership with Digital Innovations Group to integrate the IRMA AI Engine, aiming to build a diversified ecosy…

Aether Holdings Officially Launches Alphid™, Expanding Its Agentic AI Platform with Brokerage Connectivity Across More Than 30 Brokerage Firms

Aether Holdings Officially Launches Alphid™, Expanding Its Agentic AI Platform with Brokerage Connectivity Across More Than 30 Brokerage Firms

Aether Holdings, a fintech company traded on Nasdaq under ticker ATHR, has officially launched Alphid.ai, an advanced agentic AI platform now integrated with over 30 brokerage firms. This connectivity provides personalized portfolio analysis, market intelligence, and research to more than 400 million investors, transforming Alphid into a portfolio-…

BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth

BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth

BioRestorative Therapies, a Nasdaq-listed regenerative medicine company, announced the appointment of Zachary Smith as Vice President of its Biocosmeceuticals Division. Smith brings extensive commercial and sales leadership experience in aesthetics and regenerative health, aiming to accelerate commercial expansion and revenue growth in the company'…

Bond Secures Up to $3 Million in Non-Dilutive Insider Capital Through Renewal of Low Interest Credit Facility

Bond Secures Up to $3 Million in Non-Dilutive Insider Capital Through Renewal of Low Interest Credit Facility

Our Bond, Inc. announced the renewal of a revolving credit facility providing access to up to $3 million in working capital under very favorable low-interest terms. This non-dilutive facility, supported by the founder and largest shareholder, enhances the company's financial flexibility without increasing immediate debt or interest expenses unless …

SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide

SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide

Scienture Holdings, Inc. announced expanded payor coverage for its oral suspension drug Arbli™, adding approximately 12.5 million covered lives across commercial, Medicare, and Medicaid channels in the U.S. The company is enhancing pharmacy network participation and distribution capabilities to increase patient access and prescription volume in the…

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

Prime Medicine announced that New Zealand's regulatory authority approved its clinical trial application for PM577a, the company's investigational Prime Editor therapy for Wilson Disease targeting the H1069Q ATP7B gene mutation. This clearance marks the first clinical authorization for Prime Medicine's in vivo Prime Editing treatment, enabling a gl…

Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption

Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption

Bionano Genomics announced a significant 67% increase in studies featuring its optical genome mapping technology at the 2026 European Society of Human Genetics conference compared to 2025. The expanded usage spans 17 countries across five global markets and covers diverse genetic research areas such as rare disorders, cancers, and cardiovascular ge…

ZenaTech Unveils Zoo Office™, an AI-Powered Enterprise Productivity Platform Positioned to Capitalize on the Rapidly Growing Agentic AI Market

ZenaTech Unveils Zoo Office™, an AI-Powered Enterprise Productivity Platform Positioned to Capitalize on the Rapidly Growing Agentic AI Market

ZenaTech, Inc. announced the unveiling of Zoo Office™, a unified AI-powered productivity platform designed to unify and enhance its enterprise SaaS ecosystem and capitalize on the fast-growing Agentic AI market. The platform aims to automate workflows, enhance decision-making, and reduce software sprawl by providing an intelligent, connected busine…

Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026

Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026

Allarity Therapeutics (NASDAQ: ALLR), a clinical-stage biopharmaceutical company, announced the presentation of a Trial-in-Progress poster on their ongoing Phase 2 study of stenoparib, a novel dual PARP and WNT pathway inhibitor, for advanced platinum-resistant or platinum-ineligible ovarian cancer. The presentation at the ESMO Gynaecological Cance…

WISeKey’s WISe.ART Subsidiary Becomes the World’s First Hardware-Authenticated Art Platform as SEALSQ Subsidiary Secures European Patent for ‘Back-to-Physical’ NFT Technology

WISeKey’s WISe.ART Subsidiary Becomes the World’s First Hardware-Authenticated Art Platform as SEALSQ Subsidiary Secures European Patent for ‘Back-to-Physical’ NFT Technology

WISeKey International Holding Ltd announced that its WISe.ART subsidiary has become the world's first hardware-authenticated art platform. SEALSQ, another WISeKey subsidiary, secured a European Patent for 'Back-to-Physical' NFT technology that embeds NFTs directly into secure semiconductors, creating an immutable link between digital assets and phy…

Allegro MicroSystems Appoints Brian White to its Board of Directors

Allegro MicroSystems Appoints Brian White to its Board of Directors

Allegro MicroSystems has appointed Brian C. White, an experienced semiconductor industry CFO and board member, to its Board of Directors as an independent director. White's expertise in financial strategy, governance, and corporate development is expected to support Allegro's growth especially in AI data center, robotics, and automotive sectors.

Enphase Energy Begins Shipments of GaN-Based 548 VA IQ9S Commercial Microinverters in the United States

Enphase Energy Begins Shipments of GaN-Based 548 VA IQ9S Commercial Microinverters in the United States

Enphase Energy began shipments of its new IQ9S-3P Commercial Microinverter built with advanced gallium nitride (GaN) technology. This product supports high-wattage solar panels up to 770 W and three-phase 480Y/277 V grid configurations, offering improved efficiency (97.5%) and cooler operation. Manufactured in the U.S., it may qualify for federal t…

Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million

Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million

Denali Therapeutics announced an agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $195 million. The PRV was awarded following FDA accelerated approval of their enzyme replacement therapy AVLAYAH, the first FDA-approved biologic designed to cross the blood-brain barrier. Proceeds will support advancement of Denali's Tra…

One Stop Systems Announces the Appointment of Paul Averna as Vice President Business Development and Growth

One Stop Systems Announces the Appointment of Paul Averna as Vice President Business Development and Growth

One Stop Systems, a Nasdaq-listed leader in rugged high-performance computing for AI and edge applications, announced the appointment of Paul 'PK' Averna as Vice President Business Development and Growth. Averna brings over 30 years of experience in defense and commercial technology markets, expected to accelerate OSS's expansion and deepen custome…

INLIF LIMITED Announces Strategic Entry into Humanoid Robotics Market

INLIF LIMITED Announces Strategic Entry into Humanoid Robotics Market

INLIF LIMITED, a developer and manufacturer of injection molding machine-dedicated manipulator arms, is entering the humanoid robotics market. The company highlighted its progress in R&D with a humanoid robot demonstrating advanced motion capabilities such as somersaults and dynamic balance. INLIF plans to focus on high-dynamic motion control, core…